News
-
EMA: First report on sale and use of antimicrobials in animals in the EU
-
FOPH: New platform for human research in Switzerland
-
Swissmedic: Intensification of controls on international trade in medicinal products with suppliers from non-EU countries
-
Swissmedic: Publication of flyer on authorisations and drug safety in veterinary medicinal products
-
Swissmedic: Information on adverse drug reaction during treatment with a sartan and an NSAID
-
EMA: Establishment of regular procedure for scientific advice on certain high-risk medical devices
-
Swissmedic: Launch of Strategic Plan Access Consortium 2025 – 2028
-
EMA: Qualification of first artificial intelligence tool to diagnose inflammatory liver disease in biopsy samples
-
Swissmedic: Publication of report on authorisations of complementary and herbal medicinal products
-
EMA: Publication of EU medicine agencies’ network strategy to 2028
-
FOPH: New head of the Health Protection Directorate
-
Swissmedic: Newly appointed Swissmedic Expert Committees start work
-
EMA: First vaccine against epizootic haemorrhagic disease recommended for approval
-
EMA: Warning about unregulated products in the EU
-
EMA: Management board elects Rui Santos Ivo as new chair
-
Swissmedic: Publication of flyer on international authorisation procedures
-
EMA: Launch of new clinical trial map in EU
-
Swissmedic: Changes to guidance documents “authorisation of herbal medicinal products” and “information on PSUR PBRER submission HMP”
-
EMA: Issuance of two recommendations regarding medicinal products
-
EMA: Meeting highlights from the CHMP
-
Swissmedic: Information platform on questions on delimitation